Researchers reported that epidermal MHC-II drives recruitment of natural killer cells in psoriasis, triggering pyroptosis in keratinocytes and fueling disease pathology. The findings connect antigen-presentation biology at the skin surface to downstream inflammatory cell death mechanisms. The study’s emphasis on a specific immunologic axis—epidermal MHC-II, NK cell attack, and pyroptosis—creates a more defined set of intervention targets than broad immune activation models. For developers, the results sharpen mechanistic narratives that can support biomarker strategy and patient stratification in upcoming psoriasis trials, particularly where immune pathways overlap with other inflammatory dermatology indications.